![](/img/cover-not-exists.png)
A Phase II Toxicity End Point Trial (ICORG 99-09) of Accelerated Dose-escalated Hypofractionated Radiation in Non-small Cell Lung Cancer
Cagney, D.N., Thirion, P.G., Dunne, M.T., Fleming, C., Fitzpatrick, D., O'Shea, C.M., Finn, M.A., O'Sullivan, S., Booth, C., Collins, C.D., Buckney, S.J., Shannon, A., Armstrong, J.G.Language:
english
Journal:
Clinical Oncology
DOI:
10.1016/j.clon.2017.10.010
Date:
October, 2017
File:
PDF, 565 KB
english, 2017